David Neale's professional profile, showcasing his experience in managing and shaping businesses in the medical field, with expertise in cardiology, renal therapies, neuromodulation, and orthopedics.

David Neale

Randy Werneth

Argamedtech

Argá Medtech SA is a privately-held medical device company based in Switzerland founded by seasoned team of leaders in the industry. Argá is developing an innovative non-thermal energy based cardiac ablation system for the treatment of cardiac arrhythmias. With the use of Pulsed Electrical Fields (PEF) to create irreversible electroporation (IRE) of cardiomyocytes, Argá is developing a safer, faster, cheaper and more effective cardiac ablation treatment for the benefit of millions of people affected by cardiac rhythm disorders and atrial fibrillation. 

Argá Medtech SA

We are pleased to share that we closed a €54M oversubscribed Series B raise to advance the clinical studies of our innovative pulsed field ablation system for treating #atrialfibrillation. 
The financing will enable us to validate the early clinical results for our Coherent Sine-burst Electroporation™ (CSE™) ablation technology through the execution of an IDE study in the US and a CE Mark study in the EU. 
To learn more, read our full press release: https://lnkd.in/dvvaR54j
Earlybird Venture Capital Advent Life Sciences Gilde Healthcare 
#PFA #cardiacablation #argamedtech #epeeps #electrophysiology 

Earlier today, Dr. Ante Anic  presented groundbreaking data at AF Symposium 24 on the Argá Medtech Coherent Sine-burst Electroporation (CSE) ablation system. The team's hard work and dedication to developing this disruptive technology over the past 3 years culminated in the treatment of 48 patients with outstanding results. The data presented demonstrated the efficacy and flexibility of the technology, setting it apart from others in the field. Congratulations to the team on this incredible achievement! #AFSymposium24 #disruptivetechnology #medicaladvancements  
#epeeps #pfa #cardiology #electrophysiology Randy Werneth Earlybird Venture Capital Shahzad Malik Elena Marchesi John Yianni Micah Lee Melvin Lorenzo David Neale Biopôle Lausanne

Strong start for 2024! Moved to new facilities to support our future. We continue to make good and rapid progress with our Coherent Sine-burst Electroporation system, outgrowing our facilities.

@David Neale @Randy Werneth Earlybird Venture Capital #pfa #epeeps

https://lnkd.ineVHNDzrJ

Argá Medtech SA   among the 40 companies selected to present at Tech Tour Growth Health 2023 David Neale #argámedtech Earlybird Venture Capital Advent Life Sciences 

https://lnkd.in/d9fMSsCx

Busy week at #HRS2023. Argá had the opportunity to present its FIH preliminary experience, with a presentation from Melvin Lorenzo. Very strong interest in this next generation PFA device. Our unique CSE (Coherent Sine-burst Electroporation) ablation system, with its multi-configurable multi-electrode catheter can be a game changer. 

Melvin Lorenzo Micah Lee Mark Zurcher Alex Lopez Ricardo R. Kurt Hoffmayer Randy Werneth Mehdi Razavi Mark Neale Giorgi Papiashvili, MD, PhD, FESCAnte Anic #electrophysiology  #cardiology #pfa 

The Heart Rhythm Society annual conference starts in 10 days. Argá will be presenting two posters on its Coherent Sine-Burst electroporation platform.

https://lnkd.in/eYbd4iuA

#PFA

Metric
Company Name	Argamedtech
Symbol
MSH ID	COM:ARGAMEDTECH
Market	PRIVATE
Sector	8
Industry	Healthcare & Health Services
Country	CH
Stage
Employee Count	15
Website	argamedtech.com
LinkedIn	arg%C3%A1-medtech-sa
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:ARGAMEDTECH

Argamedtech

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue